论文部分内容阅读
本文报告应用抗T淋巴细胞单克隆抗体(211-1)和幼兔补体,体外处理骨髓细胞对GM-CFUc生成率无不良影响,并能清除骨髓中98%以上的 T 细胞。淋巴细胞转化试验也证明,211-1单克隆抗体可以清除骨髓中 T 细胞。
This article reports the use of anti-T lymphocyte monoclonal antibody (211-1) and baby rabbit complement, in vitro treatment of bone marrow cells on the formation of GM-CFUc adverse effects, and can clear the bone marrow more than 98% of T cells. Lymphocyte transformation test also proved that 211-1 monoclonal antibody can clear bone marrow T cells.